Izotropic Corporation (IZO.CN)
CAD 0.04
(-20.0%)
CAD 0.04
(-20.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.56 Million CAD | 72.42% |
| 2022 | -5.66 Million CAD | 15.18% |
| 2021 | -6.67 Million CAD | -34.13% |
| 2020 | -4.97 Million CAD | -330.52% |
| 2019 | -1.15 Million CAD | -190.02% |
| 2018 | -398.53 Thousand CAD | 45.42% |
| 2017 | -730.12 Thousand CAD | -642.61% |
| 2016 | -98.31 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.25 Million CAD | -757533.13% |
| 2023 Q3 | -297.53 Thousand CAD | 62.46% |
| 2023 FY | -1.56 Million CAD | 72.42% |
| 2023 Q1 | -471.34 Thousand CAD | 68.7% |
| 2023 Q2 | -792.63 Thousand CAD | -68.17% |
| 2023 Q4 | 166.00 CAD | 100.06% |
| 2022 Q2 | -1.38 Million CAD | -35.0% |
| 2022 Q1 | -1.02 Million CAD | 37.51% |
| 2022 FY | -5.66 Million CAD | 15.18% |
| 2022 Q4 | -1.5 Million CAD | 21.45% |
| 2022 Q3 | -1.91 Million CAD | -38.39% |
| 2021 Q2 | -2.55 Million CAD | -108.74% |
| 2021 Q3 | -1.23 Million CAD | 51.81% |
| 2021 Q4 | -1.64 Million CAD | -33.33% |
| 2021 FY | -6.67 Million CAD | -34.13% |
| 2021 Q1 | -1.22 Million CAD | 35.73% |
| 2020 Q2 | -371.31 Thousand CAD | 17.27% |
| 2020 FY | -4.97 Million CAD | -330.52% |
| 2020 Q4 | -1.9 Million CAD | 15.35% |
| 2020 Q3 | -2.25 Million CAD | -506.13% |
| 2020 Q1 | -448.81 Thousand CAD | 25.83% |
| 2019 Q2 | -155.38 Thousand CAD | -6.12% |
| 2019 FY | -1.15 Million CAD | -190.02% |
| 2019 Q4 | -605.14 Thousand CAD | -143.13% |
| 2019 Q1 | -146.42 Thousand CAD | -5.64% |
| 2019 Q3 | -248.89 Thousand CAD | -60.18% |
| 2018 Q2 | -94.39 Thousand CAD | -7.37% |
| 2018 Q3 | -77.62 Thousand CAD | 17.76% |
| 2018 Q4 | -138.6 Thousand CAD | -78.55% |
| 2018 FY | -398.53 Thousand CAD | 45.42% |
| 2018 Q1 | -87.91 Thousand CAD | 43.32% |
| 2017 Q3 | -68.98 Thousand CAD | 83.86% |
| 2017 Q4 | -155.11 Thousand CAD | -124.84% |
| 2017 FY | -730.12 Thousand CAD | -642.61% |
| 2017 Q1 | -78.61 Thousand CAD | -26.02% |
| 2017 Q2 | -427.41 Thousand CAD | -443.66% |
| 2016 Q2 | -22.1 Thousand CAD | -49.03% |
| 2016 Q1 | -14.83 Thousand CAD | 0.0% |
| 2016 Q4 | -62.38 Thousand CAD | -310.16% |
| 2016 FY | -98.31 Thousand CAD | 0.0% |
| 2016 Q3 | -15.21 Thousand CAD | 31.19% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioMark Diagnostics Inc. | -1.42 Million CAD | -9.386% |
| Sona Nanotech Inc. | -2.49 Million CAD | 37.538% |